Clinic significance of rapid hypersensitivity detection of Aspergillus fumigatus based on CRISPR

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000041176

Enrollment

Unknown

Registered

2020-12-20

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspergillosis

Interventions

Gold Standard:Specimen culture

Index test:CRISPR-based&#32

rapid&#32

and&#32

ultra-sensitive&#32

diagnostic&#32

test&#32

for&#32

Aspergillus&#32

fumigatus

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed as aspergillus fumigatus infection by aetiological examination

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

Measure	Time frame
Sensitivity;	—

Secondary

Measure	Time frame
Specificity;	—

Countries

China

Contacts

Public ContactJiajie Lu

Center of Infectious Diseases, West China Hospital of Sichuan Universty

10955415@qq.com+86 18980601984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026